Actuarial work helps organizations make promises under uncertainty. That responsibility is becoming more consequential as products, customer behavior, technology and business dependencies change. Our position is clear: actuarial expertise should move closer to the decisions that shape an organization’s future, supported by better data, stronger controls and responsible automation.
UNDERSTAND THE CHALLENGE
The business issue
The old approach stops working when it assumes yesterday’s experience is sufficient, the next reporting cycle is soon enough and a well-produced number will explain itself. This is a critique of an operating model—not a dismissal of established actuarial methods or the professionals using them. Classical techniques can remain appropriate and effective. The question is whether the surrounding process lets qualified people recognize change, challenge assumptions and influence action in time.
THE OCTOBER PERSPECTIVE
Ten reasons. Ten practical responses.
Historical experience can describe a different business
A long history is useful evidence, but its relevance changes when products, distribution, treatment, repair costs or policyholder behavior change. Extending a trend mechanically can preserve an assumption after its economic meaning has weakened.
In practice. A life insurer’s recent sales may have different guarantees and distribution characteristics from the portfolio used to select its original lapse assumptions. A property insurer may face a changed repair-cost environment. Neither difference proves the old method is wrong; both require investigation.
WHAT SHOULD CHANGE
Identify where experience is no longer comparable, test alternative explanations and document adjustments. Keep appropriate classical methods as benchmarks rather than replacing them on fashion alone.
Evidence and accountability. Track material assumption changes to evidence and a named reviewer. A new model should earn its place through relevant validation.
The reporting calendar is not the risk calendar
A quarterly close can be controlled and still be too slow for a material business change. Waiting for a formal valuation before investigating every signal leaves management with an avoidable blind spot.
In practice. A claims processing change alters payment patterns halfway through a period. If nobody distinguishes an operational shift from underlying claims experience, a management dashboard may suggest improvement that does not exist.
WHAT SHOULD CHANGE
Introduce proportionate monitoring between formal closes. Define thresholds for investigation and distinguish a provisional management view from an approved reporting result. Faster observation does not require uncontrolled daily changes to the official basis.
Evidence and accountability. Measure signal-to-review time and the number of material alerts that remain without an owner. The accountable actuary decides when the evidence warrants a basis change.
Fragmented data breaks the chain of evidence
When every team repairs its own extract, a final result can lose its connection to the original policy, claim or member record. Additional analytical sophistication cannot compensate for an untraceable input.
In practice. Two teams calculate a loss ratio using different premium periods and reinsurance treatments. Both calculations may be correct for their purposes, yet comparing them as if they were identical produces a false business conclusion.
WHAT SHOULD CHANGE
Agree definitions, ownership, valuation dates and reconciliation rules. Preserve source records and versioned transformations. Route exceptions to their origin instead of repeatedly fixing downstream reports.
Evidence and accountability. Test whether a reviewer can reconstruct a material result. Reconciliation completeness and unresolved exceptions are more informative than the number of connected data sources.
Portfolio averages can conceal material differences
An aggregate can remain stable while the composition of the business changes. It can also encourage excessive confidence in a small segment if the organization confuses more detail with more information.
In practice. A health portfolio adds a population with different utilization patterns. The overall average may obscure the change, while an extremely narrow subgroup analysis may be too unstable to support a decision.
WHAT SHOULD CHANGE
Examine relevant segments and composition changes, then assess credibility, permissible data use and potential unfairness. Where evidence is thin, combine suitable broader information with professional judgment and explain the uncertainty.
Evidence and accountability. Review both aggregate and segment behavior. An authorized specialist should decide whether the detail improves the decision or simply increases noise.
A single estimate cannot show the full decision risk
Boards often receive one result even when the consequences depend on a wide range of plausible outcomes. A precise-looking number can hide uncertainty in data, parameters, model structure and future conditions.
In practice. A pension sponsor can afford the central contribution path but may have limited room under an adverse scenario. A single expected amount does not show the pressure on the wider business.
WHAT SHOULD CHANGE
Present scenarios, sensitivities and—where defensible—uncertainty ranges alongside the central view. State whether a range is statistical, scenario-based or judgmental. Do not call an arbitrary sensitivity a confidence interval.
Evidence and accountability. Ask which decisions change under alternative assumptions. The owner should be able to explain the response if the central expectation is not realized.
Risks interact across organizational boundaries
Separate models can miss the mechanism that connects market movements, policyholder actions, liquidity needs and operational constraints. Combining results mechanically may conceal inconsistent assumptions or double counting.
In practice. A life insurer experiencing withdrawals may need cash when asset values are under pressure. A strategy that looks manageable in separate lapse and investment tests can become more difficult when those effects coincide.
WHAT SHOULD CHANGE
Build shared scenarios across actuarial, finance, investment and operations teams. Make dependencies explicit and challenge whether proposed management actions remain feasible under the same conditions.
Evidence and accountability. Record cross-team assumption conflicts and unresolved dependencies. Joint review is necessary; no single team should silently select everyone else’s operating assumptions.
Manual handoffs consume scarce professional attention
Repeated copying, formatting and reconciliation can crowd out the work that makes actuarial expertise valuable: interpreting uncertainty and advising the business. Manual work is not inherently bad; uncontrolled, repeated work is the problem.
In practice. An analyst prepares the same review pack from several spreadsheets each month. A late correction requires all files to be rebuilt, leaving less time for challenge before sign-off.
WHAT SHOULD CHANGE
Automate stable transformations and repeatable checks first. Keep exceptions visible and retain the ability to inspect inputs and reverse a faulty release. Use AI for bounded assistance, not to conceal unresolved differences.
Evidence and accountability. Measure rework, exception age and time available for review. Efficiency gains should be counted after control requirements are met, not by removing necessary scrutiny.
Model assurance cannot end at initial approval
A model can become less suitable as the portfolio, inputs or intended use changes. An AI-assisted process introduces additional dependencies such as prompts, retrieval sources, tool permissions and external model versions.
In practice. A validated model is reused for a new product segment without revisiting its limitations. Separately, an assistant begins summarizing evidence from a changed document collection. Prior approval does not establish that either new use is appropriate.
WHAT SHOULD CHANGE
Inventory models and their intended uses, version material dependencies and define review triggers. Use challenger approaches, outcome analysis and proportionate independent challenge. Constrain AI tools to authorized evidence and actions.
Evidence and accountability. Track unreviewed changes and uses outside the approved scope. Human reviewers must have access to the evidence and authority to reject a result.
A technically correct answer may still fail its audience
An answer loses business value when users cannot understand what it means, what it excludes or how it should affect a decision. Documentation stored elsewhere does not guarantee that the decision-maker sees a material limitation.
In practice. A board sees a favorable net result without realizing that recoverables are disputed or that the figure uses a different basis from last quarter. The issue is not arithmetic; it is interpretation.
WHAT SHOULD CHANGE
Create an explicit decision narrative: question, basis, main drivers, uncertainty, options and recommendation. Link it to the underlying evidence. AI-drafted explanations must be checked for unsupported claims and missing qualifications.
Evidence and accountability. Test the explanation with its intended audience. The accountable professional should confirm that material limitations remain visible in summaries and presentations.
An isolated actuarial function cannot close the decision loop
Actuarial recommendations can arrive too late or remain unowned when the function is treated solely as a reporting service. Better models will not fix a process in which nobody is responsible for applying and reviewing the insight.
In practice. A pricing recommendation is approved, but implementation is delayed and nobody compares the eventual portfolio with the original assumptions. The organization cannot learn whether the decision worked as intended.
WHAT SHOULD CHANGE
Design joint workflows across actuarial, business and technology teams. Assign owners for the decision, implementation and subsequent review. Develop skills in data, communication and responsible AI alongside actuarial expertise.
Evidence and accountability. Monitor actions through implementation and outcome review. Technology supports that accountability; it cannot assume the professional or executive responsibility itself.
INTERACTIVE / ILLUSTRATIVE ASSUMPTIONS
Two modest changes. One different decision.
Change the assumptions to see why independent sensitivities should also be considered together. This simplified annual claims-cost example uses 100,000 exposures, 0.08 expected claims per exposure and 2,500 currency units per claim.
Combined change: 20.96% relative to the baseline.
View calculation and accessible data table
Expected cost = exposures × expected claims per exposure × average cost per claim. Combined scenario = 20m × (1 + frequency change) × (1 + severity change).
| Scenario | Expected cost |
|---|---|
| Baseline | 20.000 |
| Frequency change only | 21.600 |
| Severity change only | 22.400 |
| Combined scenario | 24.192 |
Synthetic assumptions, not observed performance, a forecast or a calibrated actuarial model. Excludes expenses, reinsurance, discounting, development and capital. No probability distribution or confidence interval is implied. This illustration is not a pricing or reserving recommendation.
PUT IT INTO PRACTICE
What a stronger actuarial operating model looks like
We recommend a connected decision loop: define the business question, establish a trusted basis, evaluate uncertainty, challenge the result, authorize the response and monitor experience. Each stage needs an accountable person and evidence that survives the next handoff. Automation should remove repetitive work while keeping judgment visible.
The same principle applies beyond insurance. A pension sponsor needs to understand contribution uncertainty; a bank needs consistent cash-flow assumptions; a healthcare organization needs to distinguish a true cost trend from an operational delay. Actuarial capabilities become more valuable when their outputs can be used responsibly by those decision-makers.
Begin with a bounded six-week MVP
Choose one material, repeatable decision rather than replacing the entire actuarial estate. In weeks one and two, agree scope, owners, baseline measures and data definitions. In weeks three and four, connect the selected inputs and create a reproducible review pack. In weeks five and six, run alongside the existing process, challenge exceptions and test approval and rollback controls.
This is a proposed plan for a bounded MVP, subject to data access and agreed scope—not a promise to complete an organization-wide transformation in six weeks. Acceptance should depend on reconciled results, appropriate review and operational readiness. A failed gate is a reason to investigate, not a reason to relabel an incomplete control as successful.
Measure professional capacity as well as speed
The first business case should separate delivery effort, recurring operating cost and the value of better decisions. Record time spent on reconciliation, rework and explanation. Track whether a material issue reaches the responsible decision-maker sooner and whether the response is later reviewed against experience.
Do not attribute every favorable portfolio movement to a new platform. Claims, markets, mix and management decisions can change together. A defensible value assessment explains the baseline, the comparison period and factors outside the implementation. The goal is an actuarial function with more capacity to challenge and advise, not merely a faster production line.
Connect the decision to the next action
Select each step to explore the proposed workflow.
A GOVERNED DECISION SEQUENCE
Establish the decision basis
Connect the business question to approved data, assumptions and model versions.
Establish the decision basis
Connect the business question to approved data, assumptions and model versions.
Challenge before action
Compare scenarios, investigate exceptions and obtain qualified review.
Learn from the outcome
Monitor experience and reopen the decision when material evidence changes.
↻ Evidence returns to the next review. Human accountability stays visible.
Ask the leadership teamIf a material risk changed tomorrow, could our actuarial operating model detect it, explain it and support an authorized response before the next scheduled close?
MEASURE WHAT MATTERS
Evidence of a stronger process
Establish a baseline and agree targets for your organization. These are proposed measures, not claimed results.
Time from signal to decision
How long a material change takes to reach an accountable decision-maker.
Reproducibility and review
Material results reconstructed from their inputs, assumptions and approvals.
Capacity for judgment
Time available for challenge and business advice after necessary controls are met.
How Genellipse helps
Genellipse can help redesign the operating process before automating it. AegisNow can connect insurance operations with actuarial review records; GeneData can support reconciled, governed inputs; Cortex AI can assist with evidence retrieval, exception triage and review coordination. GeneComply can organize control evidence and GeneSecure can support agreed security practices. We integrate with appropriate actuarial engines and existing systems rather than assuming every model should be replaced. Professional responsibility for assumptions, methods, validation and sign-off remains explicitly assigned.
Discuss your actuarial transformationOffice of Actuarial Practice, GENELLIPSE
Sources & professional context
ASOP 56 addresses model purpose, testing, validation and controls; ASOP 23 concerns data quality; ASOP 25 concerns credibility. IFoA guidance adds ethical context for data science, and SOA research explores climate considerations. These sources support the professional context, not a claim that every actuary or organization uses an outdated approach. Standards apply according to jurisdiction and assignment.
- ASB — ASOP 56: Modeling
- ASB — ASOP 23: Data Quality
- ASB — ASOP 25: Credibility Procedures
- IFoA — Data Science Ethics
- SOA — Incorporating Climate Change into Actuarial Practice
Original Genellipse editorial analysis, prepared October 10, 2026. Sources provide professional context and do not endorse Genellipse. Illustrations are educational; an organization’s qualified advisers determine the methods, requirements and decisions appropriate to its circumstances. Product scope and integrations are agreed for each engagement.